Report highlights progress in menstrual health awareness but persistent gaps in diagnosis

A survey of 2,000 UK women who menstruate found that 45 per cent had experienced healthcare professionals dismissing persistent menstrual symptoms.
One in three respondents reported having their symptoms dismissed across multiple medical appointments.
Despite this, 64 per cent said they felt more comfortable discussing their menstrual and hormonal health than they did a decade ago.
The findings come from cycle-tracking app Clue’s 10 Years of Science report, which combines the UK survey with data from 750m tracked cycles and 40 published studies.
The report examines changing attitudes towards menstrual health and how people use digital tools to understand symptoms and seek medical support.
It found that 85 per cent of respondents recognised a connection between their menstrual cycle and overall health.
Almost half, 45 per cent, had taken cycle-tracking information or symptom records to medical appointments, while 14 per cent said this information had directly helped them secure a diagnosis or treatment plan.
Digital platforms were also identified as sources of health information.
Some 30 per cent credited peer-to-peer content on social media with improving their knowledge of their bodies, while 29 per cent said tracking apps had accelerated their understanding.
Among active cycle trackers, 94 per cent said monitoring symptoms helped them understand the different phases of their menstrual cycle.
The findings suggest that recording symptoms and recognising patterns may help people explain their experiences to healthcare professionals.
The survey also explored attitudes towards sharing personal health information for research.
Three-quarters of respondents, 75 per cent, said they would feel proud to contribute anonymised cycle-tracking data if it could help future generations receive faster diagnoses.
Looking ahead, 28 per cent wanted more research into cycle-related symptoms, while 26 per cent called for greater support around perimenopause and menopause.
The report includes five personal accounts from Clue users, covering fertility experiences, motherhood and the recognition of symptoms that helped lead to diagnoses of premenstrual dysphoric disorder (PMDD) and endometriosis.
London-based Renisa King, who has used Clue for more than a decade, described the impact of receiving a PMDD diagnosis.
She said: “Finally getting [a PMDD diagnosis] meant everything. My experiences were validated and I could finally pursue proper, targeted support to manage my symptoms effectively.”
Her experience illustrates how long-term symptom tracking can help people better understand their health concerns.
Rhiannon White, chief executive of Clue, said: “Over the past decade, we’ve seen an incredible shift in how people understand and talk about their bodies. Conversations that were once kept quiet are now happening openly, and people are using science, technology and shared experiences to better understand their health. What’s really exciting is that this knowledge doesn’t just benefit individuals.”
Clue hopes information collected through cycle tracking can contribute to further research into menstrual and reproductive health.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.








